CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $603,000 | -95.2% | 17,840 | -96.7% | 0.00% | -100.0% |
| Q1 2021 | $12,678,000 | +71.1% | 542,039 | +110.7% | 0.00% | 0.0% |
| Q4 2020 | $7,409,000 | -22.7% | 257,262 | -45.6% | 0.00% | 0.0% |
| Q3 2020 | $9,590,000 | +16.5% | 473,333 | +72.7% | 0.00% | 0.0% |
| Q2 2020 | $8,235,000 | -50.4% | 274,039 | -48.1% | 0.00% | -66.7% |
| Q1 2020 | $16,591,000 | -12.7% | 527,867 | +30.8% | 0.00% | +50.0% |
| Q4 2019 | $19,012,000 | +950500.0% | 403,575 | +15.2% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 350,225 | +0.0% | 0.00% | – |
| Q2 2019 | $4,000 | – | 350,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |